Safety
GLP-1s and Your Gallbladder
Rapid weight loss makes gallstones. That was true long before these drugs existed, and it is the mechanism behind most of the gallbladder trouble people blame on the medication itself.
This one is worth understanding properly, because the honest version is more reassuring than the headline and more actionable than “gallstones are a side effect.”
The mechanism is the weight loss
Gallstones form when bile becomes supersaturated with cholesterol and the gallbladder stops emptying properly. Rapid weight loss does both at once.
When you mobilise fat quickly, the liver secretes more cholesterol into bile. At the same time, eating less — and eating less fat in particular — means the gallbladder is stimulated to contract far less often, so bile sits there and concentrates. Stagnant, cholesterol-rich bile is precisely the recipe.
This is old knowledge. It was well described in very low calorie diets and after bariatric surgery decades before these drugs existed, and the threshold usually quoted is a loss of more than about 1.5 kg per week, which these medications make easy to exceed in the early months.
What the drug data adds
A 2022 meta-analysis in JAMA Internal Medicine pooled GLP-1 receptor agonist trials and found an increased rate of gallbladder and biliary disease, including gallstones and cholecystitis. The association was stronger at higher doses, with longer treatment, and in trials where the drug was used for weight loss rather than diabetes — which is what you would expect if the weight loss were doing most of the work, though a direct effect on gallbladder motility is also plausible.
Two things to hold at once. The relative increase is real and worth knowing. The absolute risk to any individual over a year remains low, and the conditions these drugs treat carry their own considerable risks. This is a reason to recognise the symptoms and to think about the rate of loss — not a reason to stop.
Telling it apart from ordinary side effects
This is the practically useful part, because almost everyone on these drugs has some abdominal symptoms and almost none of them are biliary.
| Feature | Ordinary GLP-1 symptoms | Biliary pain |
|---|---|---|
| Character | Queasiness, early fullness, bloating | Severe, steady pain |
| Location | Diffuse, upper abdomen | Under the right ribs, or upper middle |
| Radiation | None | Often to the right shoulder blade |
| Trigger | Dose increases, fatty meals | Fatty meals, often 1–2 hours after |
| Duration | Hours to days, dose-related | 30 minutes to a few hours, episodic |
| Pattern over time | Improves as you hold a dose | Recurs, often escalating |
The distinction that matters most: nausea is not pain. If what you are describing is genuine pain, especially severe episodic pain under the right ribs, that is worth investigating rather than absorbing as part of treatment. The broader red-flag list is in the side-effects piece.
The emergencies
Get assessed the same day for:
- Pain lasting more than 6 hours — suggests cholecystitis rather than an uncomplicated stone
- Fever or chills with abdominal pain
- Jaundice — yellowing of the eyes or skin
- Dark urine with pale stools
- Severe upper abdominal pain radiating straight through to the back, which raises pancreatitis
The last one deserves its own emphasis. Pancreatitis appears in the warnings for this drug class, gallstones are themselves a leading cause of pancreatitis, and the two problems overlap in exactly this population.
What actually reduces the risk
Slow down. The rate of weight loss is the biggest modifiable factor, and it is one more argument for a slower titration — which is also the most effective intervention for tolerability, as covered in what to do if you miss a dose. Losing 1 kg a week rather than 2 is not a worse outcome; the destination is the same and the road is safer.
Do not fast for long periods. A gallbladder that never contracts is a gallbladder making stones. Eating regularly, including some fat, keeps it moving. This is one of the few situations where a strictly fat-free approach is counterproductive — see what to actually eat.
Ask about ursodeoxycholic acid if you are losing quickly, have a history of stones, or have a strong family history. It has trial evidence for preventing stone formation during rapid weight loss and is used routinely in some bariatric programmes. It is not standard practice for everyone on a GLP-1, and it is a reasonable question rather than an unusual one.
Keep some fibre and adequate hydration, both of which are marginal contributors and both of which you should be doing anyway.
If you already have gallstones
Known asymptomatic gallstones are not an automatic contraindication, and active gallbladder disease is one of the situations requiring an individual conversation rather than a blanket rule — the full list is in who should not take a GLP-1.
What changes is the monitoring. If you have stones and start a drug that will accelerate weight loss, you and your prescriber should both know that the probability of them becoming symptomatic goes up, and you should have a plan for what happens if they do.
If you end up having it removed
Cholecystectomy is common and generally well tolerated, and most people carry on with their GLP-1 afterwards without difficulty.
Two things worth knowing. Surgery means anaesthesia, and a stomach that empties slowly is a specific consideration there — tell the team you are on this drug, for the reasons set out in GLP-1s, surgery and procedures. And a minority of people develop loose, urgent stools after gallbladder removal, from bile acids reaching the colon. That is treatable with a bile acid binder and it is worth naming, because it is easy to mistake for a drug side effect and treat with the wrong thing — as the diarrhea piece explains.
Questions I get about this month
- Does Ozempic cause gallstones?
- Partly directly and mostly through the weight loss. A 2022 meta-analysis of GLP-1 receptor agonist trials found an increased rate of gallbladder and biliary disease, with the association strongest at higher doses and longer treatment. The larger driver is that rapid weight loss of any cause supersaturates bile with cholesterol and reduces gallbladder emptying, which is exactly how stones form. The same thing happens after bariatric surgery and on very low calorie diets.
- How do I know if my pain is my gallbladder?
- Biliary pain has a recognisable pattern: severe, steady pain under the right ribs or in the upper middle abdomen, often starting within an hour or two of a fatty meal, commonly radiating to the right shoulder blade, and typically lasting from 30 minutes to a few hours. It is different from the general queasiness and early fullness these drugs cause, which is diffuse, dose-related and not usually severe. If you are describing pain rather than nausea, it is worth getting assessed.
- Can I prevent gallstones while losing weight on a GLP-1?
- The most effective lever is the rate of loss — slower titration and a gentler rate of loss reduce the risk, which is one of several reasons not to rush the schedule. Ursodeoxycholic acid has trial evidence for preventing gallstone formation during rapid weight loss and is used routinely in some bariatric programmes, so it is a reasonable thing to ask about if you are losing quickly or have a history of stones. Avoiding prolonged fasting and including some fat in meals keeps the gallbladder contracting rather than sitting still.
- When is gallbladder pain an emergency?
- Pain lasting more than about 6 hours, or accompanied by fever, chills, jaundice, or dark urine with pale stools. Those suggest cholecystitis or an obstructed bile duct rather than an uncomplicated stone, and both need same-day assessment. Severe upper abdominal pain radiating straight through to the back is a different emergency again — that pattern raises the question of pancreatitis, which also appears in the warnings for this drug class.
Sources
- 01He L et al. Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases. JAMA Internal Medicine, 2022.
- 02Uy MC et al. Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery: a meta-analysis. Obesity Surgery, 2008.
- 03FDA prescribing information, Wegovy (semaglutide) injection.
- 04Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). NEJM, 2021.
- 05Mechanick JI et al. Clinical Practice Guidelines for the Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures. Obesity, 2020.
Elise Hall, MD
Board-certified internist in Los Angeles, twenty-one years in practice. She writes about GLP-1 medications and metabolic health for people who want the reasoning, not just the conclusion — and publishes her own year on one of these drugs alongside it.
Keep reading
Supplements
The Best Supplements for GLP-1 Hair Loss
The shedding starts two to four months after the loss speeds up, which is why almost nobody connects the two. Seven supplements ranked — and one of them interferes with the blood test that rules out a heart attack.
Supplements
Best Bone Health Supplements on a GLP-1
Bone is the tissue nobody thinks about until a wrist breaks. Rapid weight loss reduces bone mineral density, the effect is largest in exactly the people most likely to be prescribed these drugs, and none of it produces a symptom until it does.
Tools
The Best GLP-1 Apps, Ranked
I scored every tracker I could get my hands on against seven criteria that matter specifically on a GLP-1 — not generic calorie counting. Here is the ranking, the rubric behind it, and where my first choice falls short.